- 
                            
                                Knowledge is needed to prevent mental health problems Mental health problems such as depression, trauma and addiction are rising across the western world. The WHO estimated in 2019 that one in eight suffered from mental health problems. With this expected to rise in the coming years. Research from Amsterdam UMC has recently shone a light on the causes as well as the ethnic differences among those who suffer from mental health problems.
- 
                            
                                Leadless pacemakers soon available for all patients Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam UMC, an improved version will soon be available for all patients. The results of this clinical trial are, today, published in the New England Journal of Medicine.
- 
                            
                                Vegan mothers' breastmilk contains two important nutrients A vegan diet does not affect maternal breastmilk concentrations of vitamin B2 and carnitine, nutrients essential for the developing infant. These are the results of an Amsterdam UMC study, presented today at the 55th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).
- 
                            
                                Stress-management interventions may help individual healthcare workers for at least a year Interventions aimed at reducing work-related stress for individual healthcare workers may lead to improvements in how people cope with stress up to a year later. Findings, from Amsterdam UMC, are today published as part of a Cochrane review.
- 
                            
                                Combination therapy outperforms chemotherapy in patients with chronic lymphocytic leukaemia Chemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukaemia (CLL). The disease is the most common form of leukaemia in the Western world, causing a substantial health burden on patients and society. It is currently incurable. Research led by researchers from Cologne University, Amsterdam UMC and Copenhagen University, now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects. The results of this study are published today in the New England Journal of Medicine.
- 
                            
                                Press @ Amsterdam UMC Our latest press releases.
- 
                            
                                Cognitive behavioural therapy lessens post-viral fatigue after COVID-19 Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioural therapy, resulting in less fatigue and concentration problems. Lead researcher, Hans Knoop, Professor of Medical Psychology at Amsterdam UMC found that “After behavioural therapy, patients not only had less symptoms but also functioned better both physically and socially. Those improvements were still present even after six months.” Today, research from Amsterdam UMC, RadboudUMC and three other hospitals is published in Clinical Infectious Diseases.
- 
                            
                                Amsterdam UMC leads an AI-powered hunt for high-risk vascular patients Every year 18 million people die from cardiovascular disease. Making it the deadliest disease in the world. Currently studies focus mainly on the heart, leaving the influence of vascular disease on these large numbers of deaths often out of sight. Despite vascular disorders being a reliable indicator for death from heart disease.
- 
                            
                                Press @ Amsterdam UMC Our press officers are happy to inform journalists of the latest developments, research findings and other newsworthy matters in the areas of patient care, research and education.
- 
                            
                                Amsterdam UMC leads international consortium in the search for treatment for ME/CFS Thanks to a ZonMw grant of more than seven million euros, Amsterdam UMC kick starts new biomedical research into ME/CFS. Jos Bosch, researcher at the University of Amsterdam and Amsterdam UMC, leads along with more than 20 partners, the hunt for answers to the following questions: What exactly happens in the body of patients? How can the diagnosis be improved? And what might be effective treatments?
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126